Active substance Avacopan
Holder     Vifor Fresenius Medical Care Renal Pharma Ltd.
Status Running
Indication in combination with a rituximab or cyclophosphamide regimen, is indicated for the treatment of adult patients with severe, active granulomatosis with polyangiitis (GPA) or microscopic polyangiitis (MPA)
Public documents Approbation
  Information for the patient
  Informed consent
Last update 05/09/2022


Last updated on 05/09/2022